TODAY2 Phase 2 Follow-up
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David M Nathan, MD
Massachusetts General Hospital
Principal Investigator - Jane L Lynch, MD
University of Texas Health Sciences Center at San Antonio
Principal Investigator - Jeanie B Tryggestad, MD
University of Oklahoma Health Science Center
Principal Investigator - Lori MB Laffel, MD
Joslin Diabetes Center
Principal Investigator - Lorraine L Katz, MD
Children's Hospital of Philadelphia
Principal Investigator - Mitchell E Geffner, MD
Children's Hospital Los Angeles
Principal Investigator - Neil H White, MD
Washington University School of Medicine
Principal Investigator - Philip S Zeitler, MD PhD
University of Colorado Denver Children's Hospital
Study Chair - Robin S Goland, MD
Columbia University Naomi Berrie Diabetes Center
Principal Investigator - Rose Gubitosi-Klug, MD
Case Western Reserve University Rainbow Babies and Children's Hospital
Principal Investigator - Ruth S Weinstock, MD PhD
SUNY Upstate Medical Center
Principal Investigator - Sherida E Tollefsen, MD
St. Louis University
Principal Investigator - Silva Arslanian, MD
University of Pittsburgh
Principal Investigator - Siripoom V McKay, MD
Baylor College of Medicine
Principal Investigator - Sonia Caprio, MD
Yale University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- University of Colorado Denver Children'S Hospital
Aurora, Colorado, United States
- Yale University School of Medicine Department of Pediatrics
New Haven, Connecticut, United States
- Joslin Diabetes Center
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Saint Louis University
St Louis, Missouri, United States
- Washington University
St Louis, Missouri, United States
- Columbia University Naomi Berrie Diabetes Center
New York, New York, United States
- Suny Upstate New York University
Syracuse, New York, United States
- Case Western Reserve University Rainbow Babies and Children'S Hospital
Cleveland, Ohio, United States
- University of Oklahoma Health Science Center
Oklahoma City, Oklahoma, United States
- Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- Children'S Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States
- Baylor College of Medicine
Houston, Texas, United States
- University of Texas Health Sciences Center
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Mar 2014
- Primary completion
- 17 Jan 2020
- Completion
- 17 Jan 2020
- Last update posted
- 5 Aug 2021
- Registered enrollment
- 517
- Registry id
- NCT02310724
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.